SERB–Hansa Idefirix Deal | Lucid Diligence Brief
SERB’s Idefirix rights acquisition from Hansa Biopharma sharpens its rare…
AI in Healthcare and Digital Health Today—May 18, 2026
This week’s AI in Healthcare and Digital Health update highlights…
SERB’s Idefirix rights acquisition from Hansa Biopharma sharpens its rare…
This week’s AI in Healthcare and Digital Health update highlights…
We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".